Cogniss opens new UK with new global headquarters in Cambridge
Posted:
Cogniss, a no-code ecosystem for digital health, has launched its new global headquarters in Cambridge, UK, as the tech company's growing user base of health innovators accelerates in the UK and Europe.
Waystar has signed a definitive agreement to acquire Iodine Software, a $1.25 billion deal that seeks to empower healthcare payments with more AI capabilities.
Read more here.
Doctors will be able to prescribe a new treatment for people with inflammatory bowel disease (IBD), after the UK medicines watchdog approved guselkumab (Tremfya) for use on the NHS.
Read more here.